Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

Clinical trial NCT05769010 · RECRUITING

Trial details

NCT number: NCT05769010
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2023-03-31
Primary completion: 2028-12-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.